Mark J Pettenati Selected Research

Combination Drug Therapy (Combination Chemotherapy)

1/2013

Burkitt's Lymphoma Presenting as Late-Onset Posttransplant Lymphoproliferative Disorder following Kidney and Pancreas Transplantation: Case Report and Review of the Literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark J Pettenati Research Topics

Disease

5	Neoplasms (Cancer) 01/2020 - 07/2004
4	Leukemia 08/2007 - 07/2004
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2005 - 02/2004
3	Chromosome Aberrations (Chromosome Abnormalities) 08/2005 - 02/2004
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2006 - 07/2004
1	Blast Crisis (Blast Phase) 01/2020
1	Disease Progression 01/2020
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020
1	Pain (Aches) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Myeloid Sarcoma (Chloroma) 01/2015
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2013
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2013
1	Hyperplasia 08/2008
1	Adenoma (Adenomas) 08/2008
1	Trisomy (Trisomies) 08/2007
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2007
1	Tetraploidy 06/2005
1	Polyploidy 06/2005
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2005
1	Chromosome Duplication 06/2005
1	Splenomegaly 01/2005
1	Philadelphia Chromosome 07/2004
1	Osteosarcoma (Osteogenic Sarcoma) 12/2003

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 08/2007 - 06/2005
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2005 - 03/2004
1	Cyclin D1IBA 01/2020
1	Tetracycline (Achromycin)FDA LinkGeneric 08/2008
1	Doxycycline (Periostat)FDA LinkGeneric 08/2008
1	AntimetabolitesIBA 08/2007
1	sargramostim (Leukine)FDA Link 10/2006
1	Imatinib Mesylate (Gleevec)FDA Link 10/2006
1	bcr-abl Fusion ProteinsIBA 10/2006
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2006
1	Core Binding Factors (Core-Binding Factor)IBA 08/2005
1	Choline-Phosphate CytidylyltransferaseIBA 06/2005
1	Etoposide (VP 16)FDA LinkGeneric 01/2005
1	Interferon alpha-2 (Roferon-A)FDA Link 07/2004

Therapy/Procedure

6	Therapeutics 01/2020 - 03/2004
2	Drug Therapy (Chemotherapy) 01/2020 - 07/2004
2	Transplantation 01/2013 - 01/2005
1	Nephrectomy 01/2015
1	Combination Drug Therapy (Combination Chemotherapy) 01/2013
1	Pancreas Transplantation 01/2013
1	Salvage Therapy 08/2005
1	Stem Cell Transplantation 02/2004
1	Surgical Amputation (Amputations) 12/2003